Fundraising Fox

Triveni

5 known investors

triveni.bio ↗

Triveni Bio is a clinical-stage biotech company using a genetics-informed approach and antibody engineering to develop therapeutics for immune and inflammatory diseases.

BiotechHealthtechin /triveni-bio

Founders & leadership

VP
Vishal Patelin

Investors · 5

Atlas VentureCambridge · $500K – $1M
Magnetic VenturesBoston · $1M – $6M
OrbiMedNew York · $1M – $75M
Ascenta CapitalreportedWilmington
Janus Henderson InvestorsreportedNew York

Funding

SEC filings, press & company announcements

$65M disclosed across 1 round · 2026

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series Bfiercebiotech.com · Aug 2026Triveni Turbine Posts Q1 FY27 Revenue Growth, Backs Overseas Units With Guarantees - TipRanks.comtipranks.com · Aug 2026Earnings call transcript: Triveni Engineering posts q1 fy 2027 profit rebound By Investing.cominvesting.com · Jul 2026Triveni Bio Raises $65M in Series C Fundingfinsmes.com · Jun 2026Triveni Bio Raises $65 Million Series C Financing to Expand Scope of First-in-Class Bispecific TRIV-573 Clinical Studies and Drive Next-Stage Company Growth - Triveni Biotriveni.bio · Jun 2026Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disordersprnewswire.com · Oct 2024

Frequently asked questions

What does Triveni do?
Triveni Bio is a clinical-stage biotech company using a genetics-informed approach and antibody engineering to develop therapeutics for immune and inflammatory diseases.
Who are Triveni's investors?
Triveni's investors include Atlas Venture, Magnetic Ventures, OrbiMed, Ascenta Capital, Janus Henderson Investors.
How much funding has Triveni raised?
Triveni has disclosed $65M raised across 1 round.